α-Galactosidase appears to decrease cardiac mass and correct the metabolic defect of Fabry's disease,
- 4 Downloads
KeywordsPlacebo Clinical Result Placebo Recipient Medium Release Ventricular Hypertrophy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 2001